[#item_full_content] The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest. Read More
[#item_full_content] The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest. Read More